Riskpilot← Back to searchSign inGet full accessJämtlandskliniken AB
ABActiveOrg 5566484951Norderön 385Other education n.e.c. · NACE 8559Est. 20030 employees
Revenue 2024
SEK -2
+100% vs 2023
EBITDA margin
2413050.0%
+8% vs 2023
Equity ratio
68.6%
Financial strength
Net profit 2024
SEK 49K
-77% vs 2023
| Revenue | SEK -2 | +100% |
| EBITDA | SEK -48K | +8% |
| Net profit | SEK 49K | -77% |
| Total assets | SEK 1,2M | -26% |
| Equity | SEK 790K | +7% |
| Employees | 0 | — |
Legal name
Jämtlandskliniken AB
Org number
5566484951
Legal form
Aktiebolag
NACE code
8559 · Other education n.e.c.
Founded
10 september 2003
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolagets verksamhet ska vara att erbjuda hälsovård, sjukvård, rehabilitering, företagshälsovård, rekreation framför allt i häloförbättrande syfte samt utbildningar inom dessa områden i Sverige och utomland och därmed förenlig verksamhet.
Address
Norderön 385
Phone
+46730369071
Email
mikael.wester@me.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | −0 | −0 | −0 |
| Staff expenses | — | — | −1 | −0 | — |
| EBITDA | −76 | −37 | −31 | −52 | −48 |
| Depreciation & amort. | −5 | −5 | −5 | −5 | −2 |
| EBIT | −81 | −42 | −35 | −57 | −50 |
| Net financials | −1 587 | −214 | −223 | 272 | 98 |
| Profit before tax | −758 | 23 | 165 | 215 | 49 |
| Tax | −0 | −30 | −78 | −8 | — |
| Net profit | −758 | −7 | 87 | 208 | 49 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 907 | 1 757 | 1 391 | 1 548 | 1 152 |
| Equity | 455 | 447 | 534 | 742 | 790 |
| Long-term debt | 721 | 728 | 620 | 673 | 233 |
| Short-term debt | 8 | 38 | 116 | 13 | 8 |
| Total debt | 729 | 766 | 737 | 686 | 241 |
EBITDA margin
-4826100.0%
This company
15.8%
Market median
-30545037% vs market
20202024
Equity ratio
68.6%
This company
38.2%
Market median
+80% vs market
20202024
Return on equity
6.2%
This company
18.4%
Market median
-66% vs market
20202024
Net profit margin
4860400.0%
This company
8.1%
Market median
+60004838% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.46×
This company
0.62×
Market median
+26% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KM Chief Executive Officer | Chief Executive Officer | 2021 |
| Former (1) | ||
UH Chief Auditor | Chief Auditor | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2024 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Jämtlandskliniken AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ulrika Helena Huss | Chief Auditor | 0 companies |
| Karl Mikael Wester | Chief Executive Officer | 0 companies |
| Chong-Hui Wester | Deputy Board Member | 0 companies |
| Bin Wester | Deputy Board Member | 0 companies |